Skip to main content
Premium Trial:

Request an Annual Quote

Amoy Diagnostics Obtains CE Mark for Cancer Mutation Assays

NEW YORK (GenomeWeb) — Chinese molecular diagnostics firm Amoy Diagnostics said today that four of its mutation analysis kits have received CE marking.

The new kits are for mutation analysis in NRAS, KRAS/NRAS, RET, and ERCC1. The company already had CE-IVD-marked tests available for EGFR, KRAS, BRAF, PIK3CA, EML4-ALK, ROS1, and AK/ROS1.

Amoy's assays are designed to detect mutations and measure gene expression in formalin-fixed, paraffin-embedded cancer tissue. They are based on a proprietary real-time PCR technology called ADx-ARMS and have been validated on several commonly used PCR instruments, the company said.

Last week, Xiamen-based Amoy said that it had named Germany's MoBiTec as the distributor for its assays in that country.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.